40 studies found for:    " August 24, 2011":" September 23, 2011"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Withdrawn Paradoxical Tuberculosis Immune Reconstitution Inflammatory Syndrome (TB-IRIS) Treatment Trial
Conditions: Immune Reconstitution Inflammatory Syndrome;   Immune Reconstitution Syndrome;   Tuberculosis;   HIV-infection/Aids
Interventions: Drug: Dexamethasone;   Drug: Atorvastatin;   Drug: Naproxen;   Drug: Placebo
22 Active, not recruiting Vitamin D Supplementation in HIV
Condition: HIV-infection/Aids
Interventions: Dietary Supplement: Vitamin D3;   Dietary Supplement: Placebo
23 Completed Etravirine Plus 2 Analogs in HIV-infected Patients
Condition: HIV-1-infection
Intervention:
24 Completed Comparative Tolerability of Protease Inhibitors
Condition: HIV
Intervention:
25 Unknown  AIMS Study: Improving HIV Treatment Adherence
Condition: HIV
Interventions: Behavioral: Usual care;   Behavioral: AIMS counseling
26 Completed The Effect of Intermittent Rifampicin on Raltegravir
Conditions: HIV;   Tuberculosis
Interventions: Drug: Raltegravir;   Drug: Rifampicin
27 Active, not recruiting Screening for Tuberculosis in HIV-infected Patients Eligible for Antiretroviral Treatment
Conditions: HIV Infection;   Tuberculosis
Intervention:
28 Recruiting Safer Sex Program for Young African-American Men
Conditions: Gonorrhea;   Chlamydia;   Trichomoniasis;   Syphilis;   HIV Infections
Intervention: Behavioral: Intervention
29 Active, not recruiting Evaluating the Safety of and Immune Response to the VSV-Indiana HIV Vaccine in Healthy, HIV-Uninfected Adults
Condition: HIV Infections
Interventions: Biological: VSV-Indiana HIV gag vaccine;   Biological: Placebo injection (normal saline)
30 Active, not recruiting Study of Late Boost Strategies for HIV-uninfected Participants From Protocol RV 144
Condition: HIV Infections
Interventions: Biological: ALVAC-HIV;   Biological: AIDSVAX B/E;   Biological: ALVAC-HIV Placebo;   Biological: AIDSVAX B/E Placebo
31 Completed Safety Study of Maraviroc's Effect on Human Osteoclasts
Conditions: HIV Infections;   AIDS
Intervention: Drug: Maraviroc
32 Completed Evaluating the Safety and Immune Response to an HIV Vaccine Boost Following the Administration of Two HIV Vaccines, in HIV-Uninfected, Healthy Adults (Study Extension to HVTN 073/SAAVI 102)
Condition: HIV Infections
Interventions: Biological: Sub C gp140 Vaccine;   Biological: MF59C.1 Adjuvant;   Other: Sodium chloride
33 Completed Improving Effective Contraceptive Use Among Opioid-maintained Women
Conditions: Contraceptive Usage;   Opioid Dependence
Interventions: Behavioral: Contraceptive management program;   Other: Usual care
34 Recruiting Three Chemo Regimens as an Adjunct to ART for Treatment of Advanced AIDS-KS
Condition: HIV-1 Infection
Interventions: Drug: Coformulated EFV/FTC/TDF;   Drug: Etoposide;   Drug: Bleomycin and Vincristine (BV);   Drug: Doxorubicin HCL Liposome Injection (PLD)
35 Completed
Has Results
Endothelial Function, Lipoproteins, and Inflammation With Low HDL Cholesterol in HIV: ER Niacin Versus Fenofibrate
Condition: HIV-1 Infection
Interventions: Drug: Niacin;   Drug: Aspirin;   Drug: Fenofibrate
36 Completed Evaluation of an Infant Feeding Intervention for HIV-exposed Haitian Infants
Condition: Lack of; Care, Infant (Child), Malnutrition
Intervention: Other: Counseling and nutrition supplement
37 Completed A South African Pilot Worksite Parenting Program to Prevent HIV Among Adolescents
Condition: Parent-Child Relations
Intervention: Behavioral: Let's Talk Worksite Parenting Program
38 Completed
Has Results
Assessmet of Patients With PAH Right Ventricular Volume
Condition: Pulmonary Arterial Hypertension
Intervention: Device: Ventripoint Medical System
39 Active, not recruiting Immune Response and Safety Study of Human Papillomavirus (HPV) Vaccine in HIV-infected Pre-adolescent in Kenya
Conditions: Genital Warts;   Cervical Cancer
Intervention: Biological: Quadrivalent HPV Vaccine
40 Terminated Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in Adults With TB Disease
Condition: Tuberculosis
Interventions: Biological: GSK Biologicals' investigational TB vaccine GSK 692342;   Biological: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page   
Indicates status has not been verified in more than two years